Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-04-11

FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)

View source ↗

Summary

The FDA approved a supplemental application for insulin lispro from Eli Lilly, supporting changes to the product related to the supplemental submission (e.g., f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DILUENT (diluents)
  • Humalog (insulin lispro)

Snippet

SUPPL AP for INSULIN LISPRO (INSULIN LISPRO)